Livzon Pharmaceutical Group Inc. 麗珠醫藥集團股份有限公司 has announced that its Board of Directors will convene on 24 March 2026. The meeting will focus on reviewing and approving the annual results for the financial year ended 31 December 2025, as well as considering a possible final dividend. Any additional business deemed necessary will also be addressed.
According to the announcement dated 2 March 2026, the Board of Livzon Pharmaceutical Group Inc. includes Executive Directors, Non-Executive Directors, an Employee Representative Director, and Independent Non-Executive Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments